Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Educational Status × 90 days × Clear all

Phase

Status

Recruiting 22 Active not recruiting 17 Not yet recruiting 5 Enrolling by invitation 3 Suspended 2 Completed 2 Withdrawn 1 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Interventions

pembrolizumab 34 Nivolumab 12 Carboplatin 10 venetoclax 9 Specimen Handling 9 Biopsy 9 Gemcitabine 8 fludarabine 7 atezolizumab 7 Radiosurgery 7 Pemetrexed 7 Magnetic Resonance Spectroscopy 7 Azacitidine 7 olaparib 6 durvalumab 6 Surveys and Questionnaires 6 Paclitaxel 6 Docetaxel 6 Cyclophosphamide 6 Trastuzumab 5 Interviews as Topic 5 Fulvestrant 5 Drug Therapy 5 tislelizumab 4 binimetinib 4 X-Rays 4 Radiotherapy 4 Radiation 4 Ipilimumab 4 Injections 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05477784 2026-01-21

EC-PC

University of Washington

Phase NA Terminated

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡